NutraLife BioSciences, Inc. (NLBS)

0.0001 0.0000 (0.00%) At close: 02:45PM EDT

NutraLife BioSciences, Inc.

6601 Lyons Road
Suite L-6
Coconut Creek, FL 33073
United States
888 509 8901
https://www.nutralifebiosciences.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 12

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Edgar Ward	Founder, President, CEO & Director	350k	N/A	1972
Mr. Nicholas E Ward	Project & Operations Manager	N/A	N/A	N/A
Dr. Kenneth L Duchin Ph.D.	Chief Clinical Developer	N/A	N/A	N/A
Dr. Hongxiang Hui M.D., Ph.D.	Chief Medical Advisor & Member of Advisory Board	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.

Corporate governance

NutraLife BioSciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.